BL PharmTech

BL PharmTech EV/FCF

The EV/FCF (Enterprise Value to Free Cash Flow) of BL PharmTech (065170.KQ) as of Oct 24, 2026 is -399.28. In the previous year, EV/FCF (Enterprise Value to Free Cash Flow) was -27.38 — a change of 1,358.07% (lower).

EV/FCF

-399.28

YoY

1,358.07%

Last updated:

EV/FCF (Enterprise Value to Free Cash Flow) of BL PharmTech is 2025 -399.28 . EV/FCF (Enterprise Value to Free Cash Flow) of BL PharmTech was 2024 -27.38 . It decreases by 1,358.07% lower compared to the previous year.

The BL PharmTech EV/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/FCF
Date
EV/FCF
Jan 1, 2018
-19.61 KRW
Jan 1, 2019
-5.63 KRW
Jan 1, 2020
-11.17 KRW
Jan 1, 2021
46.69 KRW
Jan 1, 2022
-10.71 KRW
Jan 1, 2023
14.06 KRW
Jan 1, 2024
-27.38 KRW
Jan 1, 2025
-399.28 KRW
The BL PharmTech EV/FCF history
YEAREV/FCFYoY
-399.28+1,358.07%
-27.38-294.83%
14.06-231.23%
-10.71-122.94%
46.69-518.14%
-11.17+98.20%
-5.63-71.27%
-19.61-39.59%
-32.46-43.83%
-57.79-58.55%
-139.40+6.14%
-131.34—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

BL PharmTech Stock analysis

What does BL PharmTech do? BL PharmTech Corp generates revenue through four business segments. The Health Functional Food Business segment sells red ginsengs, diet foods, and vitamins. The Cosmetics Business segment offers anti-aging skincare products. The Diagnostic and Medical Business segment provides diagnostic kits and related products. The Other segment distributes health foods and other products. Customers include consumers seeking health supplements, skincare solutions, and medical diagnostic tools. The company targets health-conscious individuals and medical professionals who purchase these specialized products. The firm's revenue streams are derived from direct sales of manufactured goods across all segments. Red ginsengs, diet foods, and vitamins are sold under the Health Functional Food Business segment. Anti-aging skincare products come from the Cosmetics Business segment. Diagnostic kits and other medical products are sold through the Diagnostic and Medical Business segment. Distribution services for health foods form the Other segment's contribution to revenue. BL PharmTech Corp's customers primarily consist of end consumers for health functional foods and cosmetics, while medical institutions purchase diagnostic kits. The company's products are distributed through retail channels and direct sales to healthcare providers. Revenue is generated from the sale of manufactured items rather than licensing or subscription models. BL PharmTech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about BL PharmTech stock

EV/FCF (Enterprise Value to Free Cash Flow) of BL PharmTech is -399.28 in 2025.

EV/FCF (Enterprise Value to Free Cash Flow) of BL PharmTech changed from -27.38 to -399.28, representing a 1,358.07% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/FCF (Enterprise Value to Free Cash Flow) BL PharmTech since 2006 – with annual values, charts, and detailed analysis.

The EV/FCF ratio measures the enterprise value relative to free cash flow. It captures the true cash-generating ability of a business.

To evaluate EV/FCF (Enterprise Value to Free Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/FCF (Enterprise Value to Free Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/FCF (Enterprise Value to Free Cash Flow)'s BL PharmTech with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — BL PharmTech

All Key Metrics — BL PharmTech